Drug
fenfluramine hydrochloride
fenfluramine hydrochloride is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Phase Distribution
Ph phase_2
1
25%
Ph phase_3
2
50%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (33.3%)
Phase 32 (66.7%)
Trials by Status
completed250%
unknown125%
not_yet_recruiting125%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingphase_3
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
NCT07503444
completedphase_3
Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).
NCT03790137
unknown
ZX008 Expanded Access Protocol
NCT03780127
completedphase_2
Fenfluramine in CDKL5 Deficiency Disorder (CDD)
NCT03861871
Clinical Trials (4)
Showing 4 of 4 trials
NCT07503444Phase 3
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
NCT03790137Phase 3
Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).
NCT03780127
ZX008 Expanded Access Protocol
NCT03861871Phase 2
Fenfluramine in CDKL5 Deficiency Disorder (CDD)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4